Rim Diab: Presenting Protein S Research as a Rebalancing Strategy at ISTH 2026
Rim Diab, Scientist-Postdoc Researcher, Research Assistant, shared a post on LinkedIn:
“Grateful for the opportunity to share our latest research at the International Society on Thrombosis and Haemostasis (ISTH) 2026.
I had the privilege of presenting our work on Protein S as a hemostatic rebalancing strategy in both Factor XI deficiency and von Willebrand disease. It was a valuable experience to discuss these projects with researchers and clinicians from around the world.
A heartfelt thank you to my supervisors, Anne Angelillo-Scherrer and Raja Prince, for their guidance, support, and encouragement throughout these projects. I am also grateful to all my colleagues and collaborators whose contributions made this work possible.
I feel very fortunate to be part of BLEEDnFIRE Therapeutics to contribute to the development of new therapeutic approaches for bleeding disorders.”
Stay updated with Hemostasis Today.
-
Jul 18, 2026, 18:00Karen Schreiber: Advancing Thrombosis Epidemiology Through Global Collaboration at ISTH 2026
-
Jul 18, 2026, 17:34Living With ITP – A New Resource for Navigating Your Diagnosis – ITP Support Association
-
Jul 18, 2026, 17:34Mona Alfaraj: It Was a Hot Week Attending ISTH 2026 Congress in Paris
-
Jul 18, 2026, 17:26Shernan Holtan: Latest Publication on PTCy
-
Jul 18, 2026, 17:20Doaa EL Demerdash: Connecting the Global ITP Community at ISTH 2026
-
Jul 18, 2026, 16:58Isabella Presch: Innovative Trial Designs for Rare Pediatric Studies
-
Jul 18, 2026, 16:36Caitlin Schneider: Research, Collaboration, and New Beginnings at ISTH 2026
-
Jul 18, 2026, 16:23Panagiota Tsiatsiou: Honored to Present Our Research at the ISTH 2026 Congress in Paris
-
Jul 18, 2026, 16:03Robert Tadevosyan: A Week of Science, Collaboration, and Growth at ISTH 2026